| Charles Hudson, MD | |
|
Concord Medical Group, 1602 Avenue Q, Lubbock, TX 79401 | |
| (972) 829-6613 | |
| (800) 611-5029 |
| Full Name | Charles Hudson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 48 Years |
| Location | Concord Medical Group, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003997768 | NPI | - | NPPES |
| 131407209 | Medicaid | TX | |
| P00204650 | Other | AR | RAILROAD MEDICARE |
| P01176879 | Other | TX | RAILROAD MEDICARE |
| 157958001 | Medicaid | AR | |
| 8DL165 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | E-4237 (Arkansas) | Secondary |
| 207Q00000X | Family Medicine | E6429 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hamilton Hospital | Olney, TX | Hospital |
| Clay County Memorial Hospital | Henrietta, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Concord Medical Group Of Texas Pllc | 7810117223 | 252 |
News Archive
The Western Australia Corruption and Crime Commission is now inquiring into the case of a senior public servant who admitted to using his position in the Health Department to personally gain around a million dollars in money and gifts between 2004 and 2009.
Epicore BioNetworks Inc. is proud to announce that the Company has been selected by TSX Venture 50 as one of the 50 strongest companies on the TSXV.
Although women have little or no control over some of the risk factors for breast cancer, such as those related to aging and genetics, they may be able to reduce their chances for developing the disease by avoiding certain environmental risks. BREAST CANCER AND THE ENVIRONMENT: A LIFE COURSE APPROACH, a new report from the Institute of Medicine, assesses the breast cancer risk posed by various environmental factors, identifies actions that offer potential to reduce women's risk for the disease, and recommends targets for future research.
Melanoma is one of the less common types of skin cancer but it accounts for the majority of the skin cancer deaths (about 75 percent).The five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence.So a great deal rides on the accuracy of the initial surgery, where the goal is to remove as little tissue as possible while obtaining "clean margins" all around the tumor.So far no imaging technique has been up to the task of defining the melanoma's boundaries accurately enough to guide surgery.Instead surgeons tend to cut well beyond the visible margins of the lesion in order to be certain they remove all the malignant tissue.Two scientists at Washington University in St. Louis have developed technologies that together promise to solve this difficult problem.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
› Verified 5 days ago
| Entity Name | Concord Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083630610 PECOS PAC ID: 0446296818 Enrollment ID: O20050707000531 |
News Archive
The Western Australia Corruption and Crime Commission is now inquiring into the case of a senior public servant who admitted to using his position in the Health Department to personally gain around a million dollars in money and gifts between 2004 and 2009.
Epicore BioNetworks Inc. is proud to announce that the Company has been selected by TSX Venture 50 as one of the 50 strongest companies on the TSXV.
Although women have little or no control over some of the risk factors for breast cancer, such as those related to aging and genetics, they may be able to reduce their chances for developing the disease by avoiding certain environmental risks. BREAST CANCER AND THE ENVIRONMENT: A LIFE COURSE APPROACH, a new report from the Institute of Medicine, assesses the breast cancer risk posed by various environmental factors, identifies actions that offer potential to reduce women's risk for the disease, and recommends targets for future research.
Melanoma is one of the less common types of skin cancer but it accounts for the majority of the skin cancer deaths (about 75 percent).The five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence.So a great deal rides on the accuracy of the initial surgery, where the goal is to remove as little tissue as possible while obtaining "clean margins" all around the tumor.So far no imaging technique has been up to the task of defining the melanoma's boundaries accurately enough to guide surgery.Instead surgeons tend to cut well beyond the visible margins of the lesion in order to be certain they remove all the malignant tissue.Two scientists at Washington University in St. Louis have developed technologies that together promise to solve this difficult problem.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
› Verified 5 days ago
| Entity Name | Comanche County Medical Center Company |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346544616 PECOS PAC ID: 3678753357 Enrollment ID: O20110825000076 |
News Archive
The Western Australia Corruption and Crime Commission is now inquiring into the case of a senior public servant who admitted to using his position in the Health Department to personally gain around a million dollars in money and gifts between 2004 and 2009.
Epicore BioNetworks Inc. is proud to announce that the Company has been selected by TSX Venture 50 as one of the 50 strongest companies on the TSXV.
Although women have little or no control over some of the risk factors for breast cancer, such as those related to aging and genetics, they may be able to reduce their chances for developing the disease by avoiding certain environmental risks. BREAST CANCER AND THE ENVIRONMENT: A LIFE COURSE APPROACH, a new report from the Institute of Medicine, assesses the breast cancer risk posed by various environmental factors, identifies actions that offer potential to reduce women's risk for the disease, and recommends targets for future research.
Melanoma is one of the less common types of skin cancer but it accounts for the majority of the skin cancer deaths (about 75 percent).The five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence.So a great deal rides on the accuracy of the initial surgery, where the goal is to remove as little tissue as possible while obtaining "clean margins" all around the tumor.So far no imaging technique has been up to the task of defining the melanoma's boundaries accurately enough to guide surgery.Instead surgeons tend to cut well beyond the visible margins of the lesion in order to be certain they remove all the malignant tissue.Two scientists at Washington University in St. Louis have developed technologies that together promise to solve this difficult problem.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
› Verified 5 days ago
| Entity Name | Concord Medical Group Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750790762 PECOS PAC ID: 7810117223 Enrollment ID: O20141007002567 |
News Archive
The Western Australia Corruption and Crime Commission is now inquiring into the case of a senior public servant who admitted to using his position in the Health Department to personally gain around a million dollars in money and gifts between 2004 and 2009.
Epicore BioNetworks Inc. is proud to announce that the Company has been selected by TSX Venture 50 as one of the 50 strongest companies on the TSXV.
Although women have little or no control over some of the risk factors for breast cancer, such as those related to aging and genetics, they may be able to reduce their chances for developing the disease by avoiding certain environmental risks. BREAST CANCER AND THE ENVIRONMENT: A LIFE COURSE APPROACH, a new report from the Institute of Medicine, assesses the breast cancer risk posed by various environmental factors, identifies actions that offer potential to reduce women's risk for the disease, and recommends targets for future research.
Melanoma is one of the less common types of skin cancer but it accounts for the majority of the skin cancer deaths (about 75 percent).The five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence.So a great deal rides on the accuracy of the initial surgery, where the goal is to remove as little tissue as possible while obtaining "clean margins" all around the tumor.So far no imaging technique has been up to the task of defining the melanoma's boundaries accurately enough to guide surgery.Instead surgeons tend to cut well beyond the visible margins of the lesion in order to be certain they remove all the malignant tissue.Two scientists at Washington University in St. Louis have developed technologies that together promise to solve this difficult problem.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Hudson, MD Po Box 99335, Fort Worth, TX 76199-0335 Ph: () - | Charles Hudson, MD Concord Medical Group, 1602 Avenue Q, Lubbock, TX 79401 Ph: (972) 829-6613 |
News Archive
The Western Australia Corruption and Crime Commission is now inquiring into the case of a senior public servant who admitted to using his position in the Health Department to personally gain around a million dollars in money and gifts between 2004 and 2009.
Epicore BioNetworks Inc. is proud to announce that the Company has been selected by TSX Venture 50 as one of the 50 strongest companies on the TSXV.
Although women have little or no control over some of the risk factors for breast cancer, such as those related to aging and genetics, they may be able to reduce their chances for developing the disease by avoiding certain environmental risks. BREAST CANCER AND THE ENVIRONMENT: A LIFE COURSE APPROACH, a new report from the Institute of Medicine, assesses the breast cancer risk posed by various environmental factors, identifies actions that offer potential to reduce women's risk for the disease, and recommends targets for future research.
Melanoma is one of the less common types of skin cancer but it accounts for the majority of the skin cancer deaths (about 75 percent).The five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence.So a great deal rides on the accuracy of the initial surgery, where the goal is to remove as little tissue as possible while obtaining "clean margins" all around the tumor.So far no imaging technique has been up to the task of defining the melanoma's boundaries accurately enough to guide surgery.Instead surgeons tend to cut well beyond the visible margins of the lesion in order to be certain they remove all the malignant tissue.Two scientists at Washington University in St. Louis have developed technologies that together promise to solve this difficult problem.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
› Verified 5 days ago
Dr. Ronald L. Cook, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St, Suite 1c143, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-2563 | |
Dr. Scott W. Dahlbeck, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 602 Indiana Ave, Lubbock, TX 79415 Phone: 806-775-8600 Fax: 806-775-8608 | |
Naticia Mortensen, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5915 82nd St, Lubbock, TX 79424 Phone: 806-794-3000 Fax: 806-698-0847 | |
Ryan Daniel Lurtsema, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 4th Street Mail Stop 9901, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-1180 | |
Dr. Cherrylene A Lindgren, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4105 I-27, Lubbock, TX 79404 Phone: 806-762-2633 Fax: 806-761-0431 | |
Jared Zachary Brinker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 |